Teplizumab: il primo farmaco “disease-modifying” approvato dall’FDA per il diabete mellito di tipo 1

Bibliographic Details

Published in:	L' endocrinologo. - Springer International Publishing, 2000. - 24(2023), 3 vom: 22. Mai, Seite 327-328
Main Author:	Soldovieri, Laura (Author)
Other Authors:	Mezza, Teresa (Author)
Format:	Article
Language:	Italian
Published:	2023
ISSN:	1720-8351
External Sources:	lizenzpflichtig